Lymphocyte deficiency limits Epstein-Barr virus latent membrane protein 1 induced chronic inflammation and carcinogenic pathology in vivo
2011

Lymphocyte Deficiency Limits Inflammation and Cancer Pathology Induced by Epstein-Barr Virus Protein

Sample size: 43 publication 10 minutes Evidence: high

Author Information

Author(s): Adele Hannigan, Asif M Qureshi, Colin Nixon, Penelope M Tsimbouri, Sarah Jones, Adrian W Philbey, Joanna B Wilson

Primary Institution: College of Medical, Veterinary & Life Sciences, University of Glasgow

Hypothesis

What role do lymphocytes play in the pathology induced by the Epstein-Barr virus latent membrane protein 1?

Conclusion

The study shows that lymphocyte presence is crucial for the progression of inflammation and cancer pathology in a mouse model expressing the Epstein-Barr virus protein.

Supporting Evidence

  • Lymphocyte elimination in the study limited the progression of skin pathology.
  • Inflammatory factors were significantly upregulated in the presence of lymphocytes.
  • The study identified a crucial role for B- and T-cells in the inflammatory response.
  • Transgenic mice showed a clear progression of skin disease correlating with lymphocyte presence.
  • Chronic inflammation was linked to the expression of the Epstein-Barr virus protein.
  • Statistical analysis showed significant differences in disease progression between lymphocyte-deficient and sufficient mice.
  • Immunoglobulin deposition was observed in the transgenic mice, indicating immune involvement.
  • Key inflammatory cytokines were found to be elevated in the transgenic model.

Takeaway

This study found that without certain immune cells, mice couldn't develop the same level of skin problems caused by a virus, suggesting those cells help the disease grow.

Methodology

The study used a transgenic mouse model to analyze the effects of the Epstein-Barr virus protein on skin inflammation and cancer development.

Potential Biases

Potential bias in interpreting results due to the specific genetic background of the mouse model used.

Limitations

The study primarily focuses on a specific mouse model, which may not fully represent human disease.

Participant Demographics

Transgenic mice expressing the Epstein-Barr virus latent membrane protein 1.

Statistical Information

P-Value

0.009

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1186/1476-4598-10-11

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication